Found 7 matching trials
A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare Facilities PHASE4 The purpose of this study is to evaluate the feasibility of conducting a st...
Show More Location
CARAES Ndera Neuro-Psychiatric Hospital
Learn More & Join Trial
A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings PHASE4 The purpose of this study is to assess the long-term symptomatic response (...
Show More Location
University Teaching Hospital of Butare(CHUB)
Learn More & Join Trial
Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia PHASE3 The purpose of this study is to demonstrate that a paliperidone palmitate 3...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Paliperidone Palmitate 6-Month Formulation PHASE3 The main purpose of this study is to assess the long-term safety and tolera...
Show More Location
Fundacion para el Estudio y Tratamiento de las Enfermedades Mentales
Learn More & Join Trial
A Study of Paliperidone Palmitate 6-Month Formulation PHASE3 The purpose of this study is to demonstrate that injection cycles consistin...
Show More Location
Woodland Research Northwest
Learn More & Join Trial
A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation PHASE3 The purpose of this study is to estimate the proportion of participants ful...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia PHASE3 The purpose of this study is to evaluate the efficacy of paliperidone palmi...
Show More Location
Multiple Locations
Learn More & Join Trial